Literature DB >> 32254013

A review of prostate cancer imaging, positron emission tomography, and radiopharmaceutical-based therapy.

Amy Pawson1, Zonia Ghumman2, Phillip H Kuo3, Hossein Jadvar4, Twyla Bartel5, Bobby Shayegan2, Katherine Zukotynski2.   

Abstract

Entities:  

Year:  2020        PMID： 32254013      PMCID： PMC7124170          DOI： 10.5489/cuaj.6506

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  61 in total

1.  Capsular transgression of prostatic carcinoma: evaluation with transrectal US with pathologic correlation.

Authors:  U M Hamper; S Sheth; P C Walsh; P M Holtz; J I Epstein
Journal:  Radiology       Date:  1991-03       Impact factor: 11.105

2.  177Lu-PSMA-617 radioligand therapy and outcome in patients with metastasized castration-resistant prostate cancer.

Authors:  Axel Bräuer; Lena Sophie Grubert; Wolfgang Roll; Andres Jan Schrader; Michael Schäfers; Martin Bögemann; Kambiz Rahbar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-06-17       Impact factor: 9.236

3.  Multisite Experience of the Safety, Detection Rate and Diagnostic Performance of Fluciclovine (18F) Positron Emission Tomography/Computerized Tomography Imaging in the Staging of Biochemically Recurrent Prostate Cancer.

Authors:  Tore Bach-Gansmo; Cristina Nanni; Peter T Nieh; Lucia Zanoni; Tronde Velde Bogsrud; Heidi Sletten; Katrine Andersen Korsan; J Kieboom; Funmilayo I Tade; Oluwaseun Odewole; Albert Chau; Penelope Ward; Mark M Goodman; Stefano Fanti; David M Schuster; Frode Willoch
Journal:  J Urol       Date:  2016-10-13       Impact factor: 7.450

4.  PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with 177Lu-Labeled PSMA-617.

Authors:  Clemens Kratochwil; Frederik L Giesel; Melsa Stefanova; Martina Benešová; Marcus Bronzel; Ali Afshar-Oromieh; Walter Mier; Matthias Eder; Klaus Kopka; Uwe Haberkorn
Journal:  J Nucl Med       Date:  2016-03-16       Impact factor: 10.057

5.  German Multicenter Study Investigating 177Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients.

Authors:  Kambiz Rahbar; Hojjat Ahmadzadehfar; Clemens Kratochwil; Uwe Haberkorn; Michael Schäfers; Markus Essler; Richard P Baum; Harshad R Kulkarni; Matthias Schmidt; Alexander Drzezga; Peter Bartenstein; Andreas Pfestroff; Markus Luster; Ulf Lützen; Marlies Marx; Vikas Prasad; Winfried Brenner; Alexander Heinzel; Felix M Mottaghy; Juri Ruf; Philipp Tobias Meyer; Martin Heuschkel; Maria Eveslage; Martin Bögemann; Wolfgang Peter Fendler; Bernd Joachim Krause
Journal:  J Nucl Med       Date:  2016-10-20       Impact factor: 10.057

6.  Carcinoma of the prostate: value of transrectal sonography in detecting extension into the neurovascular bundle.

Authors:  U M Hamper; S Sheth; P C Walsh; P M Holtz; J I Epstein
Journal:  AJR Am J Roentgenol       Date:  1990-11       Impact factor: 3.959

7.  The flare phenomenon on radionuclide bone scan in metastatic prostate cancer.

Authors:  J J Pollen; K F Witztum; W L Ashburn
Journal:  AJR Am J Roentgenol       Date:  1984-04       Impact factor: 3.959

8.  Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer.

Authors:  Ryogo Minamimoto; Andreas Loening; Mehran Jamali; Amir Barkhodari; Camila Mosci; Tatianie Jackson; Piotr Obara; Valentina Taviani; Sanjiv Sam Gambhir; Shreyas Vasanawala; Andrei Iagaru
Journal:  J Nucl Med       Date:  2015-09-24       Impact factor: 10.057

9.  Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial.

Authors:  Piet Ost; Dries Reynders; Karel Decaestecker; Valérie Fonteyne; Nicolaas Lumen; Aurélie De Bruycker; Bieke Lambert; Louke Delrue; Renée Bultijnck; Tom Claeys; Els Goetghebeur; Geert Villeirs; Kathia De Man; Filip Ameye; Ignace Billiet; Steven Joniau; Friedl Vanhaverbeke; Gert De Meerleer
Journal:  J Clin Oncol       Date:  2017-12-14       Impact factor: 44.544

10.  Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate.

Authors:  K K Hodge; J E McNeal; M K Terris; T A Stamey
Journal:  J Urol       Date:  1989-07       Impact factor: 7.450
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.